REPATRIATION MEDICAL AUTHORITY
INSTRUMENT NO. 36 OF 2008
VETERANS’ ENTITLEMENTS ACT 1986
MILITARY REHABILITATION AND COMPENSATION ACT 2004
EXPLANATORY NOTES FOR TABLING
- The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(3) & (8) of the Veterans’ Entitlements Act 1986 (the VEA) the attached Instrument No. 36 of 2008.
2. This instrument amends Statement of Principles Instrument No. 14 of 2006 concerning soft tissue sarcoma, determined under subsection 196B(3) of the VEA, by:
- Revising factor 6(i) for 'uterine sarcoma'; and
- Adding a definition of 'being obese' in clause 9.
3. The Instrument specifies a date of effect for the Instrument in accordance with sub-section 12(1)(a) of the Legislative Instruments Act 2003.
4. Prior to determining this instrument, the Authority advertised its intention to undertake an investigation in relation to soft tissue sarcoma in the Government Notices Gazette of 14 November 2007, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants. The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field. No submissions were received for consideration by the Authority during the investigation.
5. The determining of this new instrument finalises the investigation in relation to soft tissue sarcoma as advertised in the Government Notices Gazette of 14 November 2007.
6. A list of references relating to the above condition is available, on written request, from the Repatriation Medical Authority Secretariat.
Overview
The Repatriation Medical Authority Instrument No. 36 of 2008 is an amendment to Statement of Principles Instrument No. 14 of 2006, which concerns soft tissue sarcoma, under the Veterans' Entitlements Act 1986. This instrument was enacted to address specific issues related to the classification and definition of conditions relevant to veterans’ entitlements, particularly focusing on uterine sarcoma and the definition of 'being obese'. The Repatriation Medical Authority, in determining this instrument, followed a process that included advertising its intention to investigate in the Government Notices Gazette and inviting submissions from relevant organisations and experts, though no submissions were received. This instrument aims to finalise the investigation into soft tissue sarcoma and provides specific amendments to better align with current medical understanding and entitlements criteria. The policy objective is to ensure that veterans receive appropriate recognition and compensation for conditions related to their service, reflecting an updated and accurate understanding of medical conditions and their impact on eligibility for benefits.
Scope and Application
The Repatriation Medical Authority Instrument No. 36 of 2008 amends Statement of Principles Instrument No. 14 of 2006 concerning soft tissue sarcoma under the Veterans' Entitlements Act 1986. This legislation applies specifically to veterans and their dependants, particularly those with soft tissue sarcoma, and involves revising the criteria for 'uterine sarcoma' and defining 'being obese'. The amendments are made in accordance with the authority granted under subsections 196B(3) and 196B(8) of the Veterans’ Entitlements Act 1986. The instrument’s effectuates from the specified date in line with the Legislative Instruments Act 2003, ensuring that the changes are applied in a timely and legally sound manner. While the Authority invited submissions from relevant organisations and individuals during its investigation, no submissions were received. The instrument concludes the investigation announced in the Government Notices Gazette of 14 November 2007, thereby finalising the process of amending the Statement of Principles to better support affected veterans.
Key Provisions
The Repatriation Medical Authority Instrument No. 36 of 2008 amends Statement of Principles Instrument No. 14 of 2006 concerning soft tissue sarcoma, as provided under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (VEA). The primary changes introduced by this instrument include the revision of factor 6(i) to address 'uterine sarcoma' and the addition of a definition for 'being obese' in clause 9. These amendments are intended to refine the criteria for determining entitlements related to soft tissue sarcoma, ensuring that the assessment is more accurate and comprehensive.
The obligations imposed by this legislation on the parties involved are primarily centred on ensuring compliance with the revised criteria set out in the amended Statement of Principles. For the Repatriation Medical Authority, this means conducting thorough investigations and assessments in line with the updated factors and definitions. For veterans and their representatives, it means providing relevant evidence and information that aligns with the new criteria to substantiate their claims. Additionally, all relevant organisations and experts are expected to stay updated with these changes to ensure that they can offer accurate advice and support to veterans.
Failure to comply with the provisions of this instrument could lead to various consequences. Although specific offences are not detailed in the explanatory notes, breaches of the Act or failure to adhere to the updated criteria could result in disputes over entitlements. In more severe cases, misrepresentation or fraudulent claims could lead to civil or criminal penalties. While the exact penalties are not specified in these notes, penalties under the VEA can include fines and, in the case of criminal offences, imprisonment. The precise nature and severity of these penalties would depend on the specific breach and the jurisdiction in which the offence is prosecuted.
This instrument also formalises the process through which the Repatriation Medical Authority can make amendments to existing Statements of Principles. It highlights the importance of public consultation and transparency by noting that the Authority advertised its intention to investigate and invited submissions from various stakeholders. This ensures that the changes are informed by a wide range of expertise and perspectives, ultimately aiming to improve the fairness and accuracy of the entitlements process.
Overall, the Repatriation Medical Authority Instrument No. 36 of 2008 is a crucial update to the existing framework for assessing soft tissue sarcoma-related claims. It mandates specific changes to the assessment criteria and underscores the importance of adhering to these updated standards. By doing so, it aims to better serve the needs of veterans and ensure that the entitlements process remains fair and effective.